LS Kinsinger, R Harris, SH Woolf, HC Sox, KN … - Annals of internal medicine, 2002 - Am Coll Physicians Study Selection: English-language, randomized, controlled trials (RCTs) of
chemoprevention of breast cancer in women without a previous diagnosis of breast
cancer were examined, and 4 relevant trials, 3 involving tamoxifen and 1 ... Cited by 71 - Related articles - BL Direct - All 10 versions
D Sources, D Extraction, D Synthesis - Ann Intern Med, 2002 - Am Coll Physicians Study Selection: English-language, randomized, controlled trials (RCTs) of
chemoprevention of breast cancer in women without a previous diagnosis of breast
cancer were examined, and 4 relevant trials, 3 involving tamoxifen and 1 ... Related articles - All 3 versions
- ►canadianmedicaljournal.ca M Levine, JM Moutquin, R Walton, J Feightner - Canadian Medical Association Journal, 2001 - canadianmedicaljournal.ca Objective: To assist women and their physicians in making decisions regarding
the prevention of breast cancer with tamoxifen and raloxifene. ... Evidence:
Systematic review of English-language literature published from 1966 to ... Cited by 63 - Related articles - All 17 versions
LA Bastian, IM Lipkus, MN Kuchibhatla, HH … - Archives of Internal Medicine, 2001 - archinte.highwire.org Methods We conducted telephone interviews (November 3, 1997, to May 6, 1998)
among a community sample of women aged 40 to 45 and 50 to 55 years enrolled in a
randomized controlled trial to evaluate the efficacy of a tailored ... Cited by 39 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org AN Freedman, BI Graubard, SR Rao, W … - JNCI Journal of the National Cancer Institute, 2003 - jnci.oxfordjournals.org Background: The Breast Cancer Prevention Trial demonstrated that tamoxifen
treatment produced a 49% reduction in the risk of invasive breast cancer among
women at elevated risk for the disease. The US Food and Drug Administration ... Cited by 124 - Related articles - BL Direct - All 8 versions
- ►ascopubs.org RT Chlebowski, N Col, EP Winer, DE Collyar, … - Journal of Clinical Oncology, 2002 - jco.ascopubs.org Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
From the American Society of Clinical Oncology, Alexandria, VA. Cited by 137 - Related articles - BL Direct - All 6 versions
MS Cyrus-David, SS Strom - Psycho-Oncology, 2001 - interscience.wiley.com Selective estrogen receptor modulators (SERMs) are anti-estrogens that
selectively antagonize the proliferative effects of estrogens on breast cells,
thereby inhibiting or reversing neoplastic progression to clinical breast ... Cited by 13 - Related articles - BL Direct - All 2 versions
- ►nih.gov JS Haas, CP Kaplan, SE Gregorich, EJ Pérez- … - Journal of General Internal Medicine, 2004 - Springer OBJECTIVE: To investigate how physicians tailor their recom- mendations for
breast cancer prevention and risk reduction. DESIGN: Cross-sectional, mail
survey. PARTICIPANTS: Random sample of primary care physicians in ... Cited by 18 - Related articles - BL Direct - All 9 versions
S Davis, S Stewart, J Bloom - Preventive Medicine, 2004 - Elsevier Results. On average, women overestimated their risk by 25 percentage points.
Eighty percent of the respondents rated their risk of breast cancer higher than
did the assessment tool. Women rated their risk higher if they were under ... Cited by 10 - Related articles - All 5 versions
AG Mulley, K Sepucha - Annals of internal medicine, 2002 - Am Coll Physicians Women worry about many things. When the worry is about health, breast cancer
tops many women's lists. The fear is not irrational, and it often has a personal
face. Nearly 1 in 10 women has a first-degree relative with breast cancer, ... Cited by 11 - Related articles - BL Direct - All 4 versions
